Status:
COMPLETED
Epigenetics in ADHD
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
microRNAs in Attention-deficit/Hyperactivity Disorder
Eligibility:
All Genders
6-12 years
Brief Summary
Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders in children and adolescents. ADHD's nosology is largely based on clinical phenomenology that includes suc...
Detailed Description
Year 1: Recruiting 100 ADHD patients and 100 healthy control subjects (Training Set) to develop a miRNA diagnosis panel for ADHD 1\. One hundred eligible ADHD patients that are being treated in the O...
Eligibility Criteria
Inclusion
- ADHD
- Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
- The diagnosis of each child had to be made by a child psychiatrist in a structured interview that employed the Kiddie Epidemiologic Version of the Schedule for Affective Disorders and Schizophrenia (K-SADS-E)
Exclusion
- History of neuropsychiatric diseases
- Any known major physical illnesses
- Taken any medication to treat ADHD
- Health
- Inclusion Criteria:
- Age- and gender-matched children without ADHD
Key Trial Info
Start Date :
August 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
235 Patients enrolled
Trial Details
Trial ID
NCT04860024
Start Date
August 1 2015
End Date
July 1 2018
Last Update
April 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liang-Jen Wang
Kaohsiung City, Taiwan